PATENT CLAIM ANALYSIS

Application Number: 16279819
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-09
Patent Classification: ["514", "560000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Claim (Index 21):
The method of  claim 20 , wherein the fasting conditions further comprise no liquids prior to administration of the effective dose of DGLA.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.13636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15661374', '14730818', '15667683', '16198645', '14882662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7320513558598355
- 35 USC 102 Novelty (BERT): 0.5687456624674876
- Combined Prediction Score: 0.7157207865206008
- Mean Citation Score: 274.135856
- Max Citation Score: 409.79233
- Similarity Product: 284.9926926735198

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test